Australian workers to trial four-day week Consumer goods giant Unilever is expanding its four-day work week trial to Australia after impressive results in New Zealand. AAP · Nov 1, 2022
How coal miners and factory workers helped found the environmental movement Rachel Carson, a scientist and writer from rural Pennsylvania, published Silent Spring 60 years ago. Many credit this book, which meticulously documented the damage that DDT pesticides were inflicting on wildlife, farm animals and people as early as the 1950s, with launching the modern environmental movement. The Conversation · Nov 1, 2022
The Three Pillars of Effective Ketamine Mental Health Treatment By Kevin Nicholson, COO of Delic and CEO of Ketamine Wellness Centers Benzinga · Nov 1, 2022
Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More 15 Global Psychedelics Executives To Keep An Eye On In 2022 Benzinga · Nov 1, 2022
Ask an Immunity Expert: What’s Next for COVID-19? This pandemic can help us prepare for the next one, says Catherine Hankins, co-chair of Canada’s COVID-19 Immunity Task Force The Walrus · Nov 1, 2022
Indonesia revokes drug companies' licenses after 159 deaths Indonesian authorities have revoked the licenses of two pharmaceutical companies to produce syrup-type medicines following the deaths of 159 children due to acute kidney injury The Independent UK · Nov 1, 2022
How long can you test positive for Covid and when are you infectious? A surge in cases is indicating a new wave has started in the UK The Independent UK · Nov 1, 2022
Nine Covid symptoms affecting the fully vaccinated — and signs you may have it Fainting and fatigue may signal onset of variant, experts say The Independent UK · Nov 1, 2022
Who can get an autumn Covid booster jab and how do I book? Booster vaccinations are being offered to everyone in England over the age of 50 The Independent UK · Nov 1, 2022
RSV vaccine search could hit third piece of "tripledemic" threat We've got COVID boosters and flu shots. But there's a missing piece in this triad of tools to cope with what's been dubbed the tripledemic: an RSV vaccine. That could soon change. Axios · Nov 1, 2022
Strong RSV vaccine data lifts hopes after years of futility A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV The Independent UK · Nov 1, 2022
Covid remains deadly for half a million Britons, and the government isn’t talking about it As immunocompromised people and their families face a third housebound winter, Charlotte Lytton asks why the government is dragging its feet when it comes to the possibly life-altering drug Evusheld. It remains punishingly out of reach… unless you cough up the money for it The Independent UK · Nov 1, 2022
Study finds COVID-19 symptoms recur more often in those who took Paxlovid to ease illness SAN DIEGO — You've been free of COVID-19 symptoms for two days. Then the coughing, fatigue and headaches return. Join the growing number of people experiencing what's being called COVID rebound. Tribune News Service · Nov 1, 2022
Indonesia revokes firms' fever syrup licences amid inquiry into 150 deaths Indonesia's food and drug agency said on Monday it had revoked licences for syrup-type drug production by two local firms for violating manufacturing rules, as it investigates the deaths of more than 150 children due to acute kidney injury (AKI). Reuters · Nov 1, 2022
The Independent UK · Nov 1, 2022 Antibody treatment tested as new tool against malaria Research in Africa has found a one-time dose of an experimental drug protected adults against malaria for at least six months
Inverse · Oct 31, 2022 Scientists use mRNA technology to create a potent flu shot that could last for years Researchers have created an mRNA-based influenza vaccine that targets four viral proteins that tend to remain the same across different strains of influenza.
StockNews.com · Oct 31, 2022 2 Pharma Stocks You'll Want to Pay Attention to This Fall Although the stock market has been under pressure this year due to macroeconomic headwinds, the pharmaceutical industry continues to garner investor attention as it enjoys inelastic demand for its products regardless of economic conditions. Thus, fundamentally-sound pharma stocks Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) could be worth your attention…
Salon · Oct 31, 2022 When monkeypox comes to rural areas The monkeypox response in rural areas is hindered by patchy resources and bitter politics
Benzinga · Oct 31, 2022 This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out Small Pharma Inc.
The Independent UK · Oct 31, 2022 CDC director tests positive for COVID again The head of the U.S. Centers for Disease Control and Prevention has tested positive again for COVID-19
Birmingham Post · Oct 31, 2022 Binding Site sold in £2.25bn deal Company which specialises in diagnostic tools has been sold by its PE backers after an 11-year relationship
Bangkok Post · Oct 31, 2022 Indonesia revokes firms' fever syrup licences amid probe into 150 deaths JAKARTA: Indonesia's food and drug agency (BPOM) said on Monday it had revoked licenses of syrup-type drug production of two local firms for violating manufacturing rules, as it probes the deaths of more than 150 children due to acute kidney injury (AKI).
Bangkok Post · Oct 31, 2022 Exports of meth pill precursor sodium cyanide to be iced The cabinet will be asked to suspend exports of sodium cyanide for several months after large quantities of the precursor for methamphetamine pills were found to have been shipped to Myanmar, a major meth producer, authorities say.
Daily Record · Oct 31, 2022 Two cough symptoms could indicate Covid infection - including 'thick' phlegm The current coronavirus wave is being driven by a number of variants that have been circulating for several months.
Bangkok Post · Oct 31, 2022 Covid shots for young kids not popular outside Bangkok A heavily promoted campaign offering free Covid-19 vaccinations for children is getting a slow response, with parents showing reluctance.